Positron Emission Tomography and Optical Imaging of Tumor CD105 Expression with a Dual-Labeled Monoclonal Antibody

CD105 (endoglin) is an independent prognostic marker for poor prognosis in > 10 solid tumor types, including breast cancer. The goal of this study was to develop a CD105-specific agent for both positron emission tomography (PET) and near-infrared fluorescence (NIRF) imaging, which can have potent...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zhang, Yin, Hong, Hao, Engle, Jonathan W., Yang, Yunan, Theuer, Charles P., Barnhart, Todd E., Cai, Weibo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3295892/
https://ncbi.nlm.nih.gov/pubmed/22292418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp200592m
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller